Healthcare

Research and Markets has announced the addition of the 'Daily Updates: Metabolic Disorders - Tracking breaking research, drug development news new trials' subscription to their offering.

ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's Potential to Transform the Treatment of Retinal Disorders

Patients with uncontrolled asthma in Japan and the U.S. report having significantly worse quality of life and use significantly more healthcare resources than patients with controlled asthma, according to the National Health and Wellness Survey, ...

Focused on the needs of local families and children during these difficult economic times, the members of SEIU ULTCW kicked-off the Labor Day weekend by hosting the LA Fresh Start Working Families Community Festival - a free event that drew an ...

The American Red Cross has provided help and shelter from North Carolina to New England as Hurricane Earl and its winds and rain moved up the Atlantic Coast.

The Research Institute for Fragrance Materials, Inc. has now published on the RIFM web site, www.rifm.org, in the Publications section, a special issue of Food and Chemical Toxicology, Volume 48, Supplement 3, on the RIFM Human Health Group Summary,...

Exelixis, Inc. announced that today it granted restricted stock units representing an aggregate of 25,200 shares of Exelixis common stock to nine new employees. The restricted stock unit awards vest as to 1/4th of the shares subject to the ...

HeartWare International, Inc. , a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration has ...